| Literature DB >> 33906693 |
Long Zou1, Fei Zhu1, Zhong-Er Long1, Yunhong Huang2.
Abstract
Synthesis of inorganic nanomaterials such as metal nanoparticles (MNPs) using various biological entities as smart nanofactories has emerged as one of the foremost scientific endeavors in recent years. The biosynthesis process is environmentally friendly, cost-effective and easy to be scaled up, and can also bring neat features to products such as high dispersity and biocompatibility. However, the biomanufacturing of inorganic nanomaterials is still at the trial-and-error stage due to the lack of understanding for underlying mechanism. Dissimilatory metal reduction bacteria, especially Shewanella and Geobacter species, possess peculiar extracellular electron transfer (EET) features, through which the bacteria can pump electrons out of their cells to drive extracellular reduction reactions, and have thus exhibited distinct advantages in controllable and tailorable fabrication of inorganic nanomaterials including MNPs and graphene. Our aim is to present a critical review of recent state-of-the-art advances in inorganic biosynthesis methodologies based on bacterial EET using Shewanella and Geobacter species as typical strains. We begin with a brief introduction about bacterial EET mechanism, followed by reviewing key examples from literatures that exemplify the powerful activities of EET-enabled biosynthesis routes towards the production of a series of inorganic nanomaterials and place a special emphasis on rationally tailoring the structures and properties of products through the fine control of EET pathways. The application prospects of biogenic nanomaterials are then highlighted in multiple fields of (bio-) energy conversion, remediation of organic pollutants and toxic metals, and biomedicine. A summary and outlook are given with discussion on challenges of bio-manufacturing with well-defined controllability.Entities:
Keywords: Biosynthesis; Extracellular electron transfer; Inorganic nanomaterials; Metal nanoparticles; Microbial nano-factory
Year: 2021 PMID: 33906693 PMCID: PMC8077780 DOI: 10.1186/s12951-021-00868-7
Source DB: PubMed Journal: J Nanobiotechnology ISSN: 1477-3155 Impact factor: 10.435
Fig. 1Overview for biogenic nanostructured materials (metal nanoparticles and graphene) and their diverse applications
Fig. 2Mechanistic diagram for the bacterial EET. a Shewanella oneidensis MR-1, and b Geobacter sulfurreducens
Fig. 3Illustration of the thermodynamic feasibility for microbial reduction of metal ions to elemental forms under anaerobic condition (a), and the biosynthesis of MNPs through microbial reduction of metal ions both inside and outside cells (b)
Fig. 4Functions of EET components (MtrC and electron shuttle flavins) on Pd-NPs formation by S. oneidensis MR-1. a General diagram of EET pathway and genotypic effects on Pd-NPs formation. Thin section transmission electron micrographs of different strains: b, h MR-1, c ΔhydAΔhyaB, d ΔmtrCΔomcA, e MR-1 with an empty vector, ΔmtrCΔomcA with an empty vector f or mtrC vector g, and MR-1 with i 100 μM riboflavin (RF) or j 100 μM flavin mononucleotide (FMN) after 2 h reactions with 100 μM Pd2+. Scale bars represent 100 nm. k–m Nanoparticle size distributions were determined by analyzing thin section transmission electron micrographs for each strain. n Outer membrane-normalized particle counts for un-supplemented and flavin-supplemented MR-1 [81]
Fig. 5Controlling manganese doping of ZnS quantum dots by engineered S. oneidensis JG3631 with the inducible expression of MtrCAB complex. a Chemically synthesized Mn doped ZnS NPs with varying optical properties, b the amount of the inducer (TMAO) regulating expression of MtrCAB complex that performs extracellular reduction, c relationship between Mn2+ concentration and the addition of TMAO, d biogenic Mn doped ZnS quantum dots with varying optical properties as a function of Mn2+ concentration [155].
Fig. 6Schematic diagram for the EET-dependent synthesis of Se-containing nanoparticles by S. oneidensis MR-1 [160]
Summary of diverse MNPs biosynthesized by Shewanella and Geobacter species owning characteristic EET routes
| MNPs | Morphologies, Sizes and dispersity | Bacterial strains | Synthetic sites | Properties and Applications | Refs. |
|---|---|---|---|---|---|
| Monometallic | |||||
| Au | Spherical NPs (~ 12 ± 5 nm), monodisperse and hydrophilic | Extracellular | Neither toxic nor inhibitory effect on Gram-negative and Gram-positive bacteria, high biocompatibility | [ | |
| Spherical NPs (~ 10 nm) | Cell surface | – | [ | ||
| NPs (10–25 nm) | Cell surface and extracellular matrix | Partial repair of the damaged EET chain in | [ | ||
| Spherical NPs (3–11 nm) | Both intra- and extra cellular | – | [ | ||
| Spherical NPs (10–30 nm) | Extracellular | Size- and shape- dependent catalytic activity towards | [ | ||
| Spherical NPs (~ 15 nm) | Cell surface | Catalytic activity towards 4-nitrophenol reduction | [ | ||
| Spherical NPs (~ 20 nm) | Biofilm matrix | – | [ | ||
| NPs (5–50 nm) | Cell surface and Biofilm matrix | In situ promotion of EET and electricity production | [ | ||
| Ag | Spherical NPs (2–11 nm, average 4 ± 1.5 nm), monodisperse | Extracellular | Bactericidal effect on Gram-negative and Gram-positive bacteria | [ | |
| NPs (5–35 nm) | Extracellular | – | [ | ||
| Spherical NPs (8–10 nm) | Extracellular | – | [ | ||
| NPs (40.9 nm for wild-type strain, 24.4 nm for | Extracellular | Size-dependent antibacterial effect | [ | ||
| NPs (< 10 nm) grown on RGO | Extracellular | Catalytic degradation of 4-nitrophenol | [ | ||
| Pd | Nonuniform NPs | Cell surface | Catalytic degradation of polychlorinated biphenyl or perchlorate | [ | |
| NPs (either < 10 nm or ~ 50 nm) | Periplasm or cell surface | – | [ | ||
| NPs (25.8 ± 7.8 nm) | Cellular or outer-membrane | Size- and distribution-dependent catalytic degradations of nitrobenzene and | [ | ||
| Nonuniform NPs ( 5–25 nm) | - | Catalytic reduction of 4-nitrophenol to 4-aminophenol | [ | ||
| NPs (~ 13 nm) | Periplasm or cell surface | High catalytic activity towards oxygen reduction reaction | [ | ||
| NPs (4–10 nm) without aggregation | Cell surface | High catalytic efficiency of Cr6+ reduction | [ | ||
| NPs (6–8 nm) loaded on TiO2 nanotubes | Extracellular | Photocatalytic degradation of methylene blue | [ | ||
| Nonuniform NPs | predominantly in the EPS matrix surrounding cells | – | [ | ||
| NPs (5–15 nm) | Cell surface or extracellular matrix when addition of AQDS | – | [ | ||
| NPs | On cell surface and inside the periplasm | Reduction of Cr6+ to Cr3+ | [ | ||
| Se | Spherical NPs | Either in medium or attached to cell surface | – | [ | |
| Spherical NPs (~ 100 nm intracellularly, ~ 20 nm extracellularly) | Periplasmic space or cell surface | – | [ | ||
| NPs (∼50 nm) | Extracellular matrix | – | [ | ||
| Spherical NPs | Cell surface and extracellular matrix | – | [ | ||
| Spherical NPs (181 ± 40 nm, 164 ± 24 nm) | Extracellular | – | [ | ||
| Nanowires and nanoribbons | Extracellular | – | [ | ||
| Spherical NPs (100–400 nm) | Both outside and inside the cells | – | [ | ||
| Spherical NPs (50–100 nm) | Extracellular | [ | |||
| NPs (251–350 nm for wild-type strain, < 150 nm for | Extracellular | [ | |||
| Te | Needle-like NPs | Either in cytoplasm or near cytoplasmic membrane | – | [ | |
| Needle-shaped nanorods (length of 100–200 nm, width of ~ 10 nm) | Periplasmic and/or cytoplasmic spaces | – | [ | ||
| Needle-shaped nanorods (length of 89–240 nm, width of 7.5–25 nm) | Extracellular | – | [ | ||
Spherical NPs under microaerobic conditions while nanorods under aerobic conditions | Both outside and inside the cells | – | [ | ||
| Nanorods (diameter of 8–75 nm) | Intracellular | 90% degradation of methylene blue dye and anti-biofilm activity against Gram-positive and Gram-negative human pathogens | [ | ||
| Cu | NPs (20–50 nm) | Predominantly intracellular | Catalyzing azide-alkyne cycloaddition (an archetypal “click chemistry” reaction) | [ | |
| NPs (10–16 nm) on CNT surfaces | Extracellular | Catalytic reduction of 4-nitrophenol to 4-aminophenol | [ | ||
| NPs (10–16 nm) with polycrystalline nature and face centered cubic lattice | Both on cell surface and inside cells | High antibacterial against | [ | ||
| Bimetallic | |||||
| Pd/Au | Alloy NPs (6.61 nm) | On cell surface | High electrocatalytic activity and durability for ethanol and formic acid oxidation | [ | |
| Pd/Pt | Small NPs (4.41 nm), flower-shaped NPs (59.90 nm) | On cell surface | Catalytic reduction of 4-nitrophenol (activity: bio-PdPt > Bio-Pd > Bio-Pt) | [ | |
| Alloy NPs (3–40 nm), polycrystalline and face-centered-cubic structure | Inside and outside the cells | High-efficient catalytic reduction of nitrophenol and azo dyes | [ | ||
| Pd/Ag | NPs on RGO | Extracellular | Catalytic reduction of 4- nitrophenol | [ | |
| Magnetite | |||||
| Magnetite (Fe3O4) | Spherical NPs (8–15 nm) | Extracellular | – | [ | |
| Spherical NPs (26.7–37.7 nm, average 28.8 ± 3.4 nm) | Extracellular | – | [ | ||
| Spherical NPs (4–6 nm) | Extracellular | – | [ | ||
| NPs (20–30 nm) | Extracellular | Ferrimagnetic carrier supporting Pd-NPs for the Heck reaction coupling iodobenzene to ethyl acrylate or styrene | [ | ||
| NPs (10–15 nm) | Extracellular | Reduction of Cr6+ | [ | ||
| Co-doped magnetite (CoFe2O4) | Nanocrystals containing 23 atom% Co (16–8 nm) | Extracellular | An improved magnetic property | [ | |
| Zn-doped magnetite (ZnxFe3-xO4) | Spherical NPs (Zn-doping level dependent size) | Extracellular | An improved magnetic property | [ | |
| Metal chalcogenides | |||||
| AsxSy | Filamentous nanotubes (diameter of 20–100 nm, lengths up to ~ 30 μm) | Extracellular | Semiconductive and photoconductive | [ | |
| As2S3 | Nanofibers (diameter of 20–600 nm, length up to 150 μm) | Extracellular | – | [ | |
| FeS | Nanosized colloids | Extracellular | Increased bioelectricity production | [ | |
| Nanowire clusters | Extracellular | Long-distance EET | [ | ||
| Mackinawite | Extracellular | Accelerated dechlorination of trichloroethylene | [ | ||
| NPs (30–90 nm) | Extracellular | Removal of aqueous Cr6+ | [ | ||
| NPs (~ 30 nm) | Both extracellular and intracellular | FeS-NPs biosynthesis coupling with naphthol green B biodegradation | [ | ||
| Ag2S | NPs (53.4 nm for wild-type strain, 27.6 nm for | Extracellular | Catalytic reduction of methylviologen | [ | |
| Monodispersed and homogeneous spherical NPs (9 ± 3.5 nm) | Extracellular | Non-inhibitory and non-cytotoxic effect on bacteria and eukaryotic cell lines | [ | ||
| CuS | Homogenous NPs (∼5 nm), high hydrophility and stablity | Extracellular | Photothermal agent | [ | |
| Hollow CuS nano/micro shell (diameter of 17.4 nm, length of 80.8 nm) | On cell surface | Cr6+ removal | [ | ||
| ZnS | Spherical NPs (~ 5 nm) | Extracellular | Photodegradation of rhodamine B | [ | |
| Mn:ZnS | Nano quantum dots (5–10 nm) | Extracellular | – | [ | |
| CdS | NPs (15 nm) | Extracellular | Increased cytotoxic effect on brain cancer cell lines | [ | |
| NPs (4.5–11.5 nm, average 7 nm) | On cell surface | Photoreductive degradation of trypan blue | [ | ||
| NPs | On cell surface | Light-driven bio-decolorization of methyl orange | [ | ||
| CdSe | Ultrafine NPs (3.3 ± 0.6 nm) | Inside cytoplasm | Yellow fluorescence | [ | |
| HgSe | Monodispersed NPs (4.3 ± 0.79 nm) | On cell surface | – | [ | |
Fig. 7A single cell electron collector in-situ assembled with biogenic FeS-NPs for significantly increasing interfacial electron transfer efficiency at the single-cell level and electricity production. a Schematic illustration of the FeS-NPs-based collector assembly, b SEM image of S. oneidensis MR-1 cell coated with FeS-NPs, c proposed electron transfer pathway from the cell as the electron collector to an electrode, d current output of the cell under different conditions [34]
Fig. 8Bio-photo-catalytic systems produced through in-situ assembling biogenic CdS quantum dots into cells. a CdS-hybridized G. sulfurreducens PCA for bio-photo-catalytic degradation of methyl orange (MO).[30] b CdS-hybridized S. oneidensis MR-1 for bio-photo-catalytic degradation of trypan blue [159]